NRx Pharmaceuticals Prices 5.7M Share Offering, Significant Dilution Expected
Reported by Dow Jones Newswires
Sentiment
Negative
Importance
8
Price
$3.83
Mkt Cap
$167.378M
52W Low
$1.62
52W High
$5.055
Market data snapshot near publication time
Summary
NRx Pharmaceuticals has priced its public offering of 5.7 million shares of common stock. This follows the company's announcement of a proposed offering yesterday and comes after a significant Q1 revenue miss reported on May 15th. The offering represents approximately 13% dilution to existing shareholders, based on the current share count, and will provide capital likely for ongoing operations and clinical trials.
At the time of this announcement, NRXP was trading at $3.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $167.4M. The 52-week trading range was $1.62 to $5.06. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
NRXP - Latest Insights
NRXP
Jun 03, 2026, 8:18 AM EDT
NRXP
Jun 02, 2026, 5:30 PM EDT
NRXP
Jun 02, 2026, 5:28 PM EDT
NRXP
Jun 02, 2026, 4:01 PM EDT
NRXP
May 27, 2026, 7:00 AM EDT
NRXP
May 15, 2026, 4:38 PM EDT
NRXP
May 15, 2026, 4:30 PM EDT
NRXP
May 12, 2026, 7:00 AM EDT
NRXP
May 07, 2026, 8:00 AM EDT
NRXP
Apr 22, 2026, 7:00 AM EDT